Korner Assaf 4
4 · Bellerophon Therapeutics, Inc. · Filed Nov 23, 2018
Insider Transaction Report
Form 4
Korner Assaf
CFO
Transactions
- Award
Stock Option (right to buy)
2018-11-20+137,500→ 237,500 totalExercise: $0.91Exp: 2028-11-20→ Common Stock (137,500 underlying)
Footnotes (1)
- [F1]This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant.